Sevenoaks, United Kingdom · Founded 2021 · Privately Held (backing)
Developer of a small-molecule therapeutic designed to address significant unmet needs in sexual and mental well-being. Kadence Bio is based in Sevenoaks, United Kingdom and was founded in 2021. Its last reported valuation was $25.2 million in Oct 2021. It has raised $16.3 million.
Last reported valuation
$25.2M
Oct 2026
Priced at
—
Total raised
$16.3M
Last round
—
Cap table — not yet on record
Kadence Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kadence Bio with a free account
·The complete investor list: 20 names
·Watch Kadence Bio: the Monday email on marks, rounds and moves
